списана балансовая стоимость нематериальных активов
Главное меню:
Интересное
списана балансовая стоимость нематериальных активов, BRIVIACT® (brivaracetam) CV | Official HCP Site, HCP & Patient Resources | BRIVIACT® (brivaracetam) CV, Important Safety Information | HCP | BRIVIACT® (brivaracetam) CV, Adult Efficacy Data | BRIVIACT® (brivaracetam) CV, Pediatric Efficacy Data | BRIVIACT® (brivaracetam) CV, Dosing & Administration | BRIVIACT® (brivaracetam) CV, Safety & Tolerability | BRIVIACT® (brivaracetam) CV.
Neurological Adverse Reactions: BRIVIACT causes somnolence, fatigue, dizziness, and disturbance in coordination. Somnolence and fatigue-related adverse reactions were reported in 25% of adult patients taking at least 50 mg per day of BRIVIACT compared to 14% of adult patients taking placebo. Dizziness and disturbance in gait and coordination were reported in 16% of adult patients taking at least 50 mg per day of BRIVIACT compared to 10% of adult patients taking placebo. The risk is greatest early in treatment but can occur at any time. Monitor patients for these signs and symptoms and advise them not to drive or operate machinery until they have gained sufficient experience on BRIVIACT., BRIVIACT is available in oral solution, tablets, & IV formulations for patients 1 month & older with partial-onset seizures. View Safety & Prescribing Info., Explore resources to help patients & caregivers better understand & manage seizures & collaborate with their healthcare team..
The safety of BRIVIACT (brivaracetam) CV was established in phase 3 pivotal trials. View Important Safety Information for BRIVIACT (brivaracetam) CV., See adult efficacy data for BRIVIACT as a monotherapy or adjunctive therapy in partial-onset seizures. View Safety & Prescribing Info., See BRIVIACT efficacy & treatment response in pediatric clinical trials for patients 1 month & older with partial-onset seizures. View Safety & Prescribing Info., BRIVIACT offers multiple formulations: tablets, oral solution & IV. No titration required. See dosing and administration information., See safety information for BRIVIACT, including most common adverse events and DDIs., BRIVIACT pediatric long-term retention data available for patients 1 month & older with partial-onset seizures. View Safety & Prescribing Info..